Citation Impact
Citing Papers
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
2012
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
2006
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist
2011
Marine natural products
1990 Standout
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
2005
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
2009
Poly-victimization: A neglected component in child victimization
2007 Standout
Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids
2005
Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum
2011
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor
2011 StandoutNatureNobel
Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR
2007
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
2009
Identification of a novel agonist of peroxisome proliferator-activated receptors α and γ that may contribute to the anti-diabetic activity of guggulipid in Lep/Lep mice
2008
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
HDL as a target in the treatment of atherosclerotic cardiovascular disease
2005
Ligand and Receptor Dynamics Contribute to the Mechanism of Graded PPARγ Agonism
2012
Marine sponge steroids as nuclear receptor ligands
2012
Tissue-specific function of farnesoid X receptor in liver and intestine
2011
Selective liver X receptor modulators (SLiMs): What use in human health?
2011
Gut microbiota in human metabolic health and disease
2020 Standout
Deciphering the nuclear bile acid receptor FXR paradigm
2010
Understanding Desistance from Crime
2001 Standout
Ending the ‘dialogue of the deaf’: evidence and policing policies and practices. An Australian case study
2009 Standout
Therapeutic applications of pomegranate (Punica granatum L.): a review.
2008 Standout
Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure
2005
A Role of the Bile Salt Receptor FXR in Atherosclerosis
2010
SEEN AND NOW HEARD: Talking to the Targets of Open Street CCTV
1998
Methodological Issues in Working With Policy Advisers and Practitioners
2002
Space, Knowledge and Power
2016 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Mineral resources and conflicts in DRC: a case of ecological fallacy?
2013
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Less Crime, by Design
1995
Marine natural products
2018 Standout
Leads from Indian medicinal plants with hypoglycemic potentials
2006 Standout
Behind the Screens: Examining Constructions of Deviance and Informal Practices among CCTV Control Room Operators in the UK
2002 Standout
Bootstrap-Based Improvements for Inference with Clustered Errors
2008 Standout
Do Sex Offender Registration and Notification Laws Affect Criminal Behavior?
2011
HDL Therapeutics for the treatment of atherosclerosis: a brief overview of the synthetic approaches
2008
Katalytisch‐asymmetrische intramolekulare [4+2]‐Cycloaddition von in situ generierten ortho‐Chinonmethiden
2017 StandoutNobel
Estrogen Receptor β: An Overview and Update
2008
The Halicylindramides, Farnesoid X Receptor Antagonizing Depsipeptides from a Petrosia sp. Marine Sponge Collected in Korea
2016
A Space for Place in Sociology
2000 Standout
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Repeat victimization among adolescents and young adults
1995
Dynamics of the β2-Adrenergic G-Protein Coupled Receptor Revealed by Hydrogen−Deuterium Exchange
2010
Catalytic Asymmetric Intramolecular [4+2] Cycloaddition of In Situ Generated ortho‐Quinone Methides
2017 StandoutNobel
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Generation of ortho-Quinone Methides by p-TsOH on Silica and Their Hetero-Diels−Alder Reactions with Styrenes
2009
Gender, Crime, and Desistance: Toward a Theory of Cognitive Transformation
2002 Standout
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
What Have We Learned about the Resource Curse?
2014 Standout
The Situational Analysis of Crime and Deviance
1993
Works of Robert J. Barr being referenced
Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method
2008
A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor
2003
The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
2004
Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist
2003
Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia
2006
Crime Placement, Displacement, and Deflection
1990